Hofman MS - Search Results

1

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies.

Iravani A, Violet J, Azad A, Hofman MS. Iravani A, et al. Among authors: hofman ms. Prostate Cancer Prostatic Dis. 2020 Mar;23(1):38-52. doi: 10.1038/s41391-019-0174-x. Epub 2019 Oct 8. Prostate Cancer Prostatic Dis. 2020. PMID: 31595044 Review.

2

Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies.

Pattison DA, Hofman MS. Pattison DA, et al. Among authors: hofman ms. PET Clin. 2015 Oct;10(4):461-76. doi: 10.1016/j.cpet.2015.05.005. Epub 2015 Jul 3. PET Clin. 2015. PMID: 26384593 Review.

3

Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer.

Murphy DG, Hofman M, Lawrentschuk N, Maurer T. Murphy DG, et al. BJU Int. 2017 Feb;119(2):194-195. doi: 10.1111/bju.13600. BJU Int. 2017. PMID: 28090758 No abstract available.

4

Utility of ⁶⁸ Ga prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma.

Siva S, Callahan J, Pryor D, Martin J, Lawrentschuk N, Hofman MS. Siva S, et al. Among authors: hofman ms. J Med Imaging Radiat Oncol. 2017 Jun;61(3):372-378. doi: 10.1111/1754-9485.12590. Epub 2017 Jan 24. J Med Imaging Radiat Oncol. 2017. PMID: 28116853 Review.

5

Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.

Hofman MS, Iravani A. Hofman MS, et al. PET Clin. 2017 Apr;12(2):219-234. doi: 10.1016/j.cpet.2016.12.004. Epub 2017 Feb 1. PET Clin. 2017. PMID: 28267455 Review.

6

Prostate-specific membrane antigen from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer.

Violet JA, Hofman MS. Violet JA, et al. Among authors: hofman ms. BJU Int. 2017 Sep;120(3):310-312. doi: 10.1111/bju.13871. Epub 2017 May 2. BJU Int. 2017. PMID: 28380282 Review. No abstract available.

7

Detection of Synchronous Primary Malignancies with ⁶⁸Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.

Osman MM, Iravani A, Hicks RJ, Hofman MS. Osman MM, et al. Among authors: hofman ms. J Nucl Med. 2017 Dec;58(12):1938-1942. doi: 10.2967/jnumed.117.190215. Epub 2017 Jun 1. J Nucl Med. 2017. PMID: 28572488 Free article.

8

Accuracy in the Eye of the Beholder: Can We Improve Agreement in Prostate Cancer Diagnostics with PSMA PET/CT?

Hofman MS. Hofman MS. J Nucl Med. 2017 Oct;58(10):1615-1616. doi: 10.2967/jnumed.117.192542. Epub 2017 Jun 21. J Nucl Med. 2017. PMID: 28637801 Free article. No abstract available.

9

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.

Eiber M, Fendler WP, Rowe SP, Calais J, Hofman MS, Maurer T, Schwarzenboeck SM, Kratowchil C, Herrmann K, Giesel FL. Eiber M, et al. Among authors: hofman ms. J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S. doi: 10.2967/jnumed.116.186767. J Nucl Med. 2017. PMID: 28864615 Free article. Review.

10

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of ⁶⁸Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE. Hofman MS, et al. J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6. J Nucl Med. 2018. PMID: 28986512 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

300 results

Search Page